Advanced cutaneous melanoma
Clinical trials for Advanced cutaneous melanoma explained in plain language.
Never miss a new study
Get alerted when new Advanced cutaneous melanoma trials appear
Sign up with your email to follow new studies for Advanced cutaneous melanoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can an mRNA therapy supercharge the immune system against cancer?
Disease control Recruiting nowThis trial is testing an experimental therapy called STX-003, which uses mRNA to produce a protein that may help the immune system fight cancer. It is given intravenously, either alone or with the immunotherapy drug pembrolizumab (Keytruda). The study involves adults with advance…
Matched conditions: ADVANCED CUTANEOUS MELANOMA
Phase 1/2 • Sponsor: Strand Therapeutics Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Morning vs. evening: can timing boost melanoma treatment?
Disease control Recruiting nowThis study tests whether giving standard immunotherapy drugs (ipilimumab and nivolumab) in the morning works better than giving them later in the day for people with advanced melanoma that has spread or cannot be removed. About 99 adults with stage IV melanoma will be randomly as…
Matched conditions: ADVANCED CUTANEOUS MELANOMA
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC